191 related articles for article (PubMed ID: 37019064)
1. Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?
Myung JE; Strachan L; Shin J; Yim J; Lee SS
Value Health Reg Issues; 2023 Jul; 36():27-33. PubMed ID: 37019064
[TBL] [Abstract][Full Text] [Related]
2. Strengths, Weaknesses, Opportunities, and Threats Analysis of the Use of Digital Health Technologies in Primary Health Care in the Sub-Saharan African Region: Qualitative Study.
O'Brien N; Li E; Chaibva CN; Gomez Bravo R; Kovacevic L; Kwame Ayisi-Boateng N; Lounsbury O; Nwabufo NFF; Senkyire EK; Serafini A; Surafel Abay E; van de Vijver S; Wanjala M; Wangari MC; Moosa S; Neves AL
J Med Internet Res; 2023 Sep; 25():e45224. PubMed ID: 37676721
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.
Main C; Haig M; Chavez D; Kanavos P
Med Decis Making; 2024 Jan; 44(1):28-41. PubMed ID: 37882333
[TBL] [Abstract][Full Text] [Related]
4. Institute for Clinical and Economic Review - Peterson Health Technology Institute value assessment framework for digital health technologies.
Pearson SD; Singh P; Beaudoin F; Campbell J; Schapiro L; Emond SK; Pearson C
J Comp Eff Res; 2023 Dec; 12(12):e230154. PubMed ID: 37965898
[TBL] [Abstract][Full Text] [Related]
5. Delayed Patient Access to Innovative Medical Technologies in South Korea: A Lead-Time Analysis of Reimbursement Coverage Determinations.
Lee SS; Myung JE; Strachan L
Int J Technol Assess Health Care; 2019 Jan; 35(3):229-236. PubMed ID: 31218976
[TBL] [Abstract][Full Text] [Related]
6. Evolving provider payment models and patient access to innovative medical technology.
Long G; Mortimer R; Sanzenbacher G
J Med Econ; 2014 Dec; 17(12):883-93. PubMed ID: 25221929
[TBL] [Abstract][Full Text] [Related]
7. Health Expenditure Growth under Single-Payer Systems: Comparing South Korea and Taiwan.
Cheng SH; Jin HH; Yang BM; Blank RH
Value Health Reg Issues; 2018 May; 15():149-154. PubMed ID: 29730247
[TBL] [Abstract][Full Text] [Related]
8. Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation.
Lee SS; Salole E
Value Health; 2014 Jun; 17(4):476-81. PubMed ID: 24969010
[TBL] [Abstract][Full Text] [Related]
9. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
Sim B; Ju JH; Kim B; Lee JY
JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
[TBL] [Abstract][Full Text] [Related]
10. Health Technology Assessment for Cardiovascular Digital Health Technologies and Artificial Intelligence: Why Is It Different?
Vervoort D; Tam DY; Wijeysundera HC
Can J Cardiol; 2022 Feb; 38(2):259-266. PubMed ID: 34461229
[TBL] [Abstract][Full Text] [Related]
11. Mobile Safety Alarms Based on GPS Technology in the Care of Older Adults: Systematic Review of Evidence Based on a General Evidence Framework for Digital Health Technologies.
Ehn M; Richardson MX; Landerdahl Stridsberg S; Redekop K; Wamala-Andersson S
J Med Internet Res; 2021 Oct; 23(10):e27267. PubMed ID: 34633291
[TBL] [Abstract][Full Text] [Related]
12. Eight-year experience of using HTA in drug reimbursement: South Korea.
Bae EY; Hong JM; Kwon HY; Jang S; Lee HJ; Bae S; Yang BM
Health Policy; 2016 Jun; 120(6):612-20. PubMed ID: 27086557
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on current status of health technology reassessment: insights for South Korea.
Seo HJ; Park JJ; Lee SH
Health Res Policy Syst; 2016 Nov; 14(1):82. PubMed ID: 27835964
[TBL] [Abstract][Full Text] [Related]
14. Lessons for Vietnam on the Use of Digital Technologies to Support Patient-Centered Care in Low- and Middle-Income Countries in the Asia-Pacific Region: Scoping Review.
Kosowicz L; Tran K; Khanh TT; Dang TH; Pham VA; Ta Thi Kim H; Thi Bach Duong H; Nguyen TD; Phuong AT; Le TH; Ta VA; Wickramasinghe N; Schofield P; Zelcer J; Pham Le T; Nguyen TA
J Med Internet Res; 2023 Apr; 25():e43224. PubMed ID: 37018013
[TBL] [Abstract][Full Text] [Related]
15. Patient advocacy group involvement in health technology assessments: an observational study.
Single A; Cabrera A; Fifer S; Tsai J; Paik JY; Hope P
Res Involv Engagem; 2021 Nov; 7(1):83. PubMed ID: 34823610
[TBL] [Abstract][Full Text] [Related]
16. Drug reimbursement decision-making in Thailand, China, and South Korea.
Ngorsuraches S; Meng W; Kim BY; Kulsomboon V
Value Health; 2012; 15(1 Suppl):S120-5. PubMed ID: 22265058
[TBL] [Abstract][Full Text] [Related]
17. Innovative Medical Technology, Health Technology Assessment, and Health Policy: The Case of Remote Patient Monitoring of Cardiac Implantable Electronic Devices in South Korea.
Lee SS; Salole E
Telemed J E Health; 2017 Jan; 23(1):25-29. PubMed ID: 27285669
[TBL] [Abstract][Full Text] [Related]
18. Application of the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies in Assessing Mobile-Delivered Technologies for the Self-Management of Type 2 Diabetes Mellitus: Scoping Review.
Forsyth JR; Chase H; Roberts NW; Armitage LC; Farmer AJ
JMIR Diabetes; 2021 Feb; 6(1):e23687. PubMed ID: 33591278
[TBL] [Abstract][Full Text] [Related]
19. Selecting digital health technologies for validation and piloting by healthcare providers: a decision-making perspective from ontario.
Chahal A; Rudnick A
Int J Technol Assess Health Care; 2019 Jan; 35(1):1-4. PubMed ID: 30714547
[TBL] [Abstract][Full Text] [Related]
20. Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report.
Perugini M; Johnson TJ; Beume TM; Dong OM; Guerino J; Hu H; Kerr K; Kindilien S; Nuijten M; Ofili TU; Taylor M; Wong A; Freijer K
Value Health; 2022 May; 25(5):677-684. PubMed ID: 35500942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
